Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir by Victoria Hendrick, Erast Pohorylo, Lubna Merchant, Jackie Gerhart, Iqra Naz Arham, Florin Draica, Romina Quercia, Ayman Ayoub, Reema Mehta

Subjects: Get full text

Potential drug interaction after withdrawal of nirmatrelvir-ritonavir in hospitalized patients with COVID-19 infection by Yun Han, Yonglan Gou, Jieqiong Liu, Lingyan Yu, Yuhua Zhao, Zhenwei Yu

Subjects: Get full text

Real-world effectiveness of simnotrelvir-ritonavir versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 during the omicron wave in China: a retrospective cohort stu... by Chuntao Li, Qingzhao Cheng, Ying Chen, Ling Liu, Dajin Liu, Jiaqiang Zhang, Zehua Liao, Yaling Xiang, Jinbiao Zhou, Keke Liao, Yandi Su, Xuemei Zhang, Jiashu Li, Yuping Zhao, Yue Yang, Jianqing Zhang, Long Yang

Subjects: Get full text

Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances by S. A. Zolotov, N. B. Demina, E. S. Ponomarev, I. A. Dain, A. S. Zolotova

Subjects: “…ritonavir…”
Get full text

Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause? by Hasan M. Shihab, Fred Lutwama, Theresa Piloya, Barbara Castelnuovo, Andrew D. Kambugu, Robert Colebunders

Subjects: Get full text

Application of nirmatrelvir/ritonavir for the treatment of severe COVID-19 in a 3-year-old child by Xia Wang, Shuyan Quan, Zhifeng Wu, Yuping Zhang, Enyi Wen, Jingbin Huang, Wang Yang

Subjects: Get full text

Exploring the therapeutic mechanism of itraconazole combined with ritonavir on Candida albicans infection through network pharmacology and molecular docking by Yiyang Feng, Wenli Feng, Jing Yang, Yan Ma

Subjects: Get full text

Efficacy of Nirmatrelvir tablet/Ritonavir tablet in patients infected with COVID-19 aged 90 years and older by WEI Xueman, ZHANG Jingxiang, LIU Tan

Subjects: Get full text

Development and Validation of Atazanavir and Ritonavir Determination in Human Plasma by HPLC-MS Method by T. N. Komarov, I. E. Shohin, O. A. Miskiv, D. S. Bogdanova, A. V. Aleshina, Yu. V. Medvedev, N. S. Bagaeva

Subjects: Get full text

Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study by Guozhang Lin, Yuchen Wei, Zihao Guo, Huwen Wang, Kate Ching Ching Chan, Renee Wan Yi Chan, Chi Tim Hung, Xiaoting Jiang, Conglu Li, Carrie Ho Kwan Yam, Tsz Yu Chow, Yawen Wang, Shi Zhao, Kehang Li, Aimin Yang, Chris Ka Pun Mok, David S. C. Hui, Eng Kiong Yeoh, Ka Chun Chong

Subjects: Get full text

Severe COVID-19 infection in a kidney transplant recipient treated with lopinavir/ritonavir, hydroxychloroquine and dexamethasone by Satriyo Dwi Suryantoro, Mochammad Thaha, Pranawa, Djoko Santoso, Nunuk Mardiana, Widodo, Aditiawardana, Artaria Tjempakasari, Ardityo Rahmat Ardhany, Dana Pramudya, Decsa Medika Hertanto, Evy Febriane, Meryana, Maria Angela, Ari Christy Muliono, Handoko Tanuwidjaja, Philia Setiawan, David Sugiarto

Subjects: Get full text

Effectiveness and safety of azvudine versus nirmatrelvir/ritonavir in hospitalized patients with COVID-19 by Jin Yang, Jiao Min, Ling Ding, Rong Liu, Ya Yang, Jian-feng Zhang, Wei Lei

Subjects: Get full text

Bioequivalence study of generic nirmatrelvir in healthy volunteers by R. A. Oseshnyuk, A. G. Nikiforova, A. Yu. Boroduleva, P. D. Sobolev, S. A. Lesnichuk, B. B. Garyaev, A. A. Abramova, V. G. Mozgovaya, O. V. Filon, A. V. Zinkovskaya, A. N. Dolgorukova, E. K. Khanonina, V. G. Ignatiev, M. Yu. Samsonov

Subjects: Get full text

Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment for COVID-19: “Symptom Rebound” by Ashish Bhargava, Susan Szpunar, Mamta Sharma, Louis Saravolatz

Subjects: Get full text

What’s new in the etiotropic therapy of coronavirus infection? by A. V. Budnevsky

Subjects: Get full text

IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION by V. B. Denisenko, E. N. Simovanyan

Subjects: Get full text

Real-world effectiveness and economic analysis of nirmatrelvir/ritonavir, remdesivir, and molnupiravir for treatment of COVID-19 among ambulatory patients in Thailand by Sirapat Korwiwattanakan, Surangkana Samanloh, Pinyo Rattanaumpawan

Subjects: Get full text

Association between nirmatrelvir/ritonavir treatment and antibiotic prescribing in the outpatient setting among patients with COVID-19 by Aisling R. Caffrey, Haley J. Appaneal, Vrishali V. Lopes, Thomas Lavoie, Laura Puzniak, Evan J. Zasowski, Luis Jodar, Iqra Arham, Kerry L. LaPlante, John M. McLaughlin

Subjects: Get full text

MODERN DIRECTED ANTIVIRAL COVID-19 THERAPY: RESULTS OF MULTICENTER CLINICAL EFFECTIVENESS AND SAFETY STUDY OF FIXED NIRMATRELVIR+RITONAVIR COMBINATION by L. A. Balykova, N. M. Selezneva, E. I. Gorshenina, O. I. Shepeleva, N. V. Kirichenko, E. N. Simakina, K. B. Kolontarev, D. Yu. Pushkar, D. N. Zemskov, K. Ya. Zaslavskaya, S. M. Noskov, A. V. Taganov, P. A. Bely

Subjects: Get full text

Lopinavir/ritonavir as part of schemes of HAARt in HIV-positive pregnant women and women of reproductive age: the dynamics of clinical and immunological and virological indicators by A. B. Konkova-Reidman, O. L. Ruhtina, Yu. I. Bulankov

Subjects: Get full text